The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2008, 181, 5730 -5737
Copyright © 2008 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vincent, T.
Right arrow Articles by Antel, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vincent, T.
Right arrow Articles by Antel, J. P.
Right arrowPubmed/NCBI databases
*Substance via MeSH

Functional Consequences of Neuromyelitis Optica-IgG Astrocyte Interactions on Blood-Brain Barrier Permeability and Granulocyte Recruitment1

Thierry Vincent*,{dagger}, Philippe Saikali{dagger}, Romain Cayrol{ddagger}, Alejandro D. Roth{dagger},§, Amit Bar-Or{dagger}, Alexandre Prat{ddagger} and Jack P. Antel2,{dagger}

* Laboratoire d’Immunologie, Hôpital Saint-Eloi-CHU Montpellier, Montpellier, France; {dagger} Neuroimmunology Unit, and Experimental Therapeutics Program, Montreal Neurological Institute, McGill University, and {ddagger} Neuroimmunology Research Laboratory, Centre Hospitalier de l’Université de Montréal–Notre-Dame Hospital, Université de Montréal, Montréal, Québec, Canada; and § Department of Biology, Faculty of Science, Universidad de Chile, Santiago, Chile

Autoantibody neuromyelitis optica-IgG (NMO-IgG) recognizing aquaporin-4 (AQP4) is implicated as playing a central role in the physiopathology of NMO. The aim of this in vitro-based study was to characterize functional consequences of interaction between NMO-IgG and cells of the neurovascular unit (astrocytes and brain endothelium) that would provide insight into recognized features of NMO, namely altered blood-brain barrier (BBB) permeability and granulocyte recruitment. We used sera from NMO and longitudinally extensive transverse myelitis cases shown to bind in a characteristic perivascular pattern to primate cerebellar slices. Using flow cytometry, we found that sera from NMO-IgG-positive patients reacted with CNS-derived human fetal astrocytes, whereas sera from multiple sclerosis patients did not. We demonstrated that NMO-IgG binding to astrocytes alters aquaporin-4 polarized expression and increases permeability of a human BBB endothelium/astrocyte barrier. We further demonstrated that NMO-IgG binding to human fetal astrocytes can result in NK cell degranulation, astrocyte killing by Ab-dependent cellular cytotoxicity and complement-dependent granulocyte attraction through the BBB model. Our study highlights important functional roles for NMO-IgG that could account for pathological lesions and BBB dysfunction observed in NMO.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This study was supported by grants from the Canadian Institutes of Health Research, by the Multiple Sclerosis Society of Canada (MSSC) and by the Canadian Foundation for Innovation (to A.P., A.B.-O., and J.P.A.). A.B.-O. is recipient of the MSSC Don Paty Award and McGill Dawson Scholar. A.P. holds a Donald Paty Career Development Award of the MSSC and is a Research scholar from the Fond de la Recherche en Santé du Québec. P.S. and R.C. hold studentships from the MSSC and from the Neuroinflammation Training Program of the Canadian Institutes for Health Research.

2 Address correspondence and reprint requests Dr. Jack P. Antel, Neuroimmunology Unit, Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, Quebec H3A 2B4, Canada; E-mail address: jack.antel{at}mcgill.ca

3 Abbreviations used in this paper: NMO, neuromyelitis optica; MS, multiple sclerosis; AQP4, aquaporin-4; HFA, human fetal astrocyte; BBB, blood-brain barrier; EC, endothelial cell; GFAP, glial fibrillary acidic protein; ADCC, Ab-dependent cellular cytotoxicity.




This article has been cited by other articles:


Home page
Arch NeurolHome page
S. R. Hinson, A. McKeon, J. P. Fryer, M. Apiwattanakul, V. A. Lennon, and S. J. Pittock
Prediction of Neuromyelitis Optica Attack Severity by Quantitation of Complement-Mediated Injury to Aquaporin-4-Expressing Cells
Arch Neurol, September 1, 2009; 66(9): 1164 - 1167.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Nishiyama, T. Ito, T. Misu, T. Takahashi, A. Kikuchi, N. Suzuki, K. Jin, M. Aoki, K. Fujihara, and Y. Itoyama
A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset
Neurology, June 2, 2009; 72(22): 1960 - 1961.
[Full Text] [PDF]


Home page
Mult SclerHome page
M Nakamura, T Misu, K Fujihara, I Miyazawa, I Nakashima, T Takahashi, S Watanabe, and Y Itoyama
Occurrence of acute large and edematous callosal lesions in neuromyelitis optica
Multiple Sclerosis, June 1, 2009; 15(6): 695 - 700.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.